Publications by authors named "Engy Refaie"

Claim this Profile
C
Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease.
Samuel J Martínez-Domínguez, Sandra García-Mateo, Carla J Gargallo-Puyuelo, Beatriz Gallego Llera, Engy Refaie

Eur J Intern Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling the cellular response to the SARS-COV-2 vaccine in inflammatory bowel disease patients on biologic drugs.
Samuel J Martínez-Domínguez, Sandra García-Mateo, Pilar Sainz-Arnal, Javier Martínez-García, Beatriz Gallego-Llera, Engy Refaie

Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease.
Engy Refaie, Sandra García Mateo, Samuel Jesús Martínez Domínguez, Carla Jerusalén Gargallo-Puyuelo, Laura Lario Quilez

Gastroenterol Hepatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis